Hepatocellular carcinoma is a leading cause of cancer-related death globally. The treatment of hepatocellular carcinoma is complex, with diverse therapeutic approaches and their combinations available ...

Although chronic infection with hepatitis B virus and/or hepatitis C virus are the most important risk factors for hepatocellular ... importance of nonviral liver disease-related HCC is expected ...

Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.

Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...

Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...

Eating vegetables can help reduce the risk of liver cancer by 65 per cent, according to a study. The study, led by ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.

The study, led by researchers from the INSERM, the French National Institute of Health and Medical Research, focused on ...

Bilirubin is not normally present in urine and indicates either bile duct obstruction or intrinsic hepatic disease. Elevated levels of urobilinogen may indicate hemolysis or hepatocellular disease.